import type { Metadata } from 'next';
import { Breadcrumbs } from '@/components/breadcrumbs';
import { ShareBar } from '@/components/share-bar';
import { AutoLink } from '@/components/auto-link';
import { RelatedPosts } from '@/components/related-posts';
import Link from 'next/link';
import { ChevronRight, Calendar, User, ArrowRight, ShieldAlert, BookOpen, AlertCircle } from 'lucide-react';
import { CiteThisPage } from '@/components/cite-page';
import { AuthorBio } from '@/components/author-bio';
import { SHORT_DISCLAIMER } from '@/data/constants';
import { LibraryCallout } from '@/components/library-callout';
import { getAuthorSlug } from '@/data/authors';
import { BlogVendorCallout } from '@/components/blog-vendor-callout';

const POST_TITLE = 'BPC-157 vs TB-500: What the Research Actually Shows';
const POST_DESC = 'An in-depth clinical analysis comparing the mechanisms, half-lives, and synergistic tissue repair effects of combining BPC-157 with TB-500 in preclinical models.';
const AUTHOR = 'Dr. E. Vance';
const DATE_PUB = '2026-03-28';
const DATE_MOD = '2026-04-01';

export const metadata: Metadata = {
  title: `${POST_TITLE} | PeptiDex Research`,
  description: POST_DESC,
  alternates: {
    canonical: 'https://peptidex.app/blog/bpc-157-vs-tb-500',
  },
  openGraph: {
    title: `${POST_TITLE} | PeptiDex Research`,
    description: POST_DESC,
    url: 'https://peptidex.app/blog/bpc-157-vs-tb-500',
    type: 'article',
    images: [{
      url: `https://peptidex.app/api/og?type=blog&title=${encodeURIComponent(POST_TITLE)}`,
      width: 1200,
      height: 630,
      alt: POST_TITLE,
    }],
  },
  twitter: {
    card: 'summary_large_image',
    title: `${POST_TITLE} | PeptiDex Research`,
    description: POST_DESC,
  },
};

export default function BlogPostTemplate() {
  
  // SEO Schemas
  const breadcrumbSchema = {
    '@context': 'https://schema.org',
    '@type': 'BreadcrumbList',
    itemListElement: [
      { '@type': 'ListItem', position: 1, name: 'Home', item: 'https://peptidex.app/' },
      { '@type': 'ListItem', position: 2, name: 'Blog', item: 'https://peptidex.app/blog' },
      { '@type': 'ListItem', position: 3, name: POST_TITLE, item: 'https://peptidex.app/blog/bpc-157-vs-tb-500' },
    ],
  };

  const articleSchema = {
    '@context': 'https://schema.org',
    '@type': 'Article',
    headline: POST_TITLE,
    description: POST_DESC,
    image: 'https://peptidex.app/og-image.png',
    author: { '@type': 'Person', name: AUTHOR },
    publisher: {
      '@type': 'Organization',
      name: 'PeptiDex',
      logo: { '@type': 'ImageObject', url: 'https://peptidex.app/logo.png' }
    },
    datePublished: DATE_PUB,
    dateModified: DATE_MOD,
  };

  const faqSchema = {
    '@context': 'https://schema.org',
    '@type': 'FAQPage',
    mainEntity: [
      {
        '@type': 'Question',
        name: 'Can you stack BPC-157 and TB-500 together?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'Yes, in preclinical research, they are frequently stacked because they utilize completely different metabolic pathways. BPC-157 focuses on angiogenesis and localized repair, while TB-500 focuses on actin upregulation and systemic cell migration.',
        },
      },
      {
        '@type': 'Question',
        name: 'Which is better for tendon repair: BPC-157 or TB-500?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'Current animal models suggest BPC-157 provides superior outcomes for direct tendon-to-bone healing and ligament repair, whereas TB-500 is often more effective for muscle tears and broad inflammation reduction.',
        },
      },
      {
        '@type': 'Question',
        name: 'Are BPC-157 and TB-500 legal?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'Both compounds are legal strictly for in-vitro and preclinical laboratory research as raw analytical chemicals. They are not FDA-approved for human consumption.',
        },
      },
    ],
  };

  return (
    <div className="max-w-4xl mx-auto px-4 py-8 md:py-12 relative space-y-12">
      <script type="application/ld+json" dangerouslySetInnerHTML={{ __html: JSON.stringify(articleSchema) }} />
      <script type="application/ld+json" dangerouslySetInnerHTML={{ __html: JSON.stringify(faqSchema) }} />

      {/* Breadcrumbs */}
      <Breadcrumbs items={[
        { name: 'Home', url: 'https://peptidex.app/' },
        { name: 'Blog', url: 'https://peptidex.app/blog' },
        { name: '{POST_TITLE}' }
      ]} />

      {/* Top Disclaimer */}
      <div className="rounded-xl bg-amber-950/25 border border-amber-500/20 p-4">
        <div className="flex items-start gap-2">
          <ShieldAlert className="w-5 h-5 text-amber-500 flex-shrink-0 mt-0.5" />
          <p className="text-sm text-amber-400/80 leading-relaxed font-medium">
            <strong>RESEARCH USE ONLY:</strong> {SHORT_DISCLAIMER}
          </p>
        </div>
      </div>

      {/* Article Header (E-E-A-T) */}
      <header className="space-y-6">
        <h1 className="text-3xl md:text-5xl lg:text-5xl font-extrabold tracking-tight text-zinc-100 leading-tight">
          {POST_TITLE}
        </h1>
        
        <div className="flex flex-wrap items-center gap-4 text-sm text-zinc-400 border-t border-b border-zinc-800/50 py-4">
          <div className="flex items-center gap-2">
            <User className="w-4 h-4 text-violet-400" />
            <Link href={`/about/${getAuthorSlug(AUTHOR)}`} className="font-semibold text-zinc-200 hover:text-violet-400 transition-colors">{AUTHOR}</Link>
          </div>
          <div className="w-1.5 h-1.5 rounded-full bg-zinc-700" />
          <div className="flex items-center gap-2">
            <Calendar className="w-4 h-4 text-zinc-500" />
            <span>Updated: {DATE_MOD}</span>
          </div>
          <div className="w-1.5 h-1.5 rounded-full bg-zinc-700" />
          <div className="flex items-center gap-2">
            <BookOpen className="w-4 h-4 text-emerald-500" />
            <span className="text-emerald-400 font-medium">8 Min Read</span>
          </div>
        </div>
        <ShareBar title={POST_TITLE} url={`https://peptidex.app/blog/bpc-157-vs-tb-500`} />
      </header>

      {/* Main Content Layout */}
      <div className="grid grid-cols-1 lg:grid-cols-12 gap-12">
        
        {/* Table of Contents - Sidebar */}
        <aside className="lg:col-span-4 lg:order-2">
          <div className="sticky top-24 rounded-2xl bg-zinc-900/40 border border-zinc-800 p-6 space-y-4 shadow-xl">
            <h3 className="font-bold text-zinc-100 uppercase tracking-widest text-xs">Table of Contents</h3>
            <ul className="space-y-3 text-sm font-medium text-zinc-400">
              <li><a href="#introduction" className="hover:text-violet-400 transition-colors block">1. The Golden Standard Stack</a></li>
              <li><a href="#mechanisms" className="hover:text-violet-400 transition-colors block">2. Divergent Cellular Mechanisms</a></li>
              <li><a href="#clinical-differences" className="hover:text-violet-400 transition-colors block">3. Localized vs Systemic Action</a></li>
              <li><a href="#how-they-stack" className="hover:text-violet-400 transition-colors block">4. How the Research Prepares the Stack</a></li>
              <li><a href="#sourcing" className="hover:text-violet-400 transition-colors block">5. Sourcing Verified Compounds</a></li>
            </ul>
          </div>
          
          <div className="mt-8">
            <h3 className="font-bold text-zinc-100 mb-4 text-sm uppercase tracking-widest">Related Profiles</h3>
            <div className="space-y-3">
               <Link href="/peptides/bpc-157" className="flex items-center justify-between p-3 rounded-xl bg-zinc-900 border border-zinc-800 hover:border-violet-500/50 transition-colors group">
                 <span className="font-semibold text-zinc-200 group-hover:text-violet-400">BPC-157 (PL-14736)</span>
                 <ArrowRight className="w-4 h-4 text-zinc-500 group-hover:text-violet-400 group-hover:translate-x-1 transition-transform" />
               </Link>
               <Link href="/peptides/tb-500" className="flex items-center justify-between p-3 rounded-xl bg-zinc-900 border border-zinc-800 hover:border-violet-500/50 transition-colors group">
                 <span className="font-semibold text-zinc-200 group-hover:text-violet-400">TB-500 (Thymosin Beta-4)</span>
                 <ArrowRight className="w-4 h-4 text-zinc-500 group-hover:text-violet-400 group-hover:translate-x-1 transition-transform" />
               </Link>
            </div>
          </div>
        </aside>

        {/* Prose Content */}
        <AutoLink>
        <main className="lg:col-span-8 lg:order-1 prose prose-invert prose-zinc max-w-none prose-h2:text-2xl prose-h2:mt-12 prose-h3:text-lg prose-a:text-violet-400 hover:prose-a:text-violet-300">
          <p className="lead text-xl text-zinc-300 font-medium" id="introduction">
            When examining preclinical models for severe musculoskeletal regeneration, two compounds consistently emerge at the top of the literature: <strong>BPC-157</strong> and <strong>TB-500</strong>.
          </p>
          <p>
            While both peptides are celebrated for accelerating recovery in animal subjects, they achieve these outcomes through fundamentally different biological pathways. Understanding these distinct pathways is critical for researchers aiming to deploy synergistic protocols.
          </p>
          <p className="p-4 bg-violet-900/10 border border-violet-500/20 rounded-xl my-6 text-zinc-300">
            For researchers sourcing these compounds, <a href="https://aminoclub.com?utm_source=affiliate_marketing&code=PEPTIDEX" target="_blank" rel="noopener noreferrer" className="font-semibold text-violet-400 hover:underline">Amino Club provides COA-verified peptides with documented purity testing. Browse peptides &rarr;</a>
          </p>


          <h2 id="mechanisms">Divergent Cellular Mechanisms</h2>
          <p>
            The fundamental difference between the two peptides boils down to how they influence the cellular environment following acute trauma.
          </p>
          
          <h3 className="flex items-center gap-2 text-violet-300 border-b border-zinc-800 pb-2">BPC-157: The Angiogenesis Director</h3>
          <p>
            Body Protection Compound-157 is primarily an angiogenic (blood-vessel forming) mediator. Research demonstrates that BPC-157 dramatically upregulates VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) in rodents. By stimulating new blood vessel arrays around damaged tendon fibers, BPC-157 ensures the injured site receives the metabolic fuel necessary to execute rapid fibroblastic deployment. 
          </p>

          <h3 className="flex items-center gap-2 text-emerald-300 border-b border-zinc-800 pb-2">TB-500: The Systemic Migrator</h3>
          <p>
            Conversely, TB-500 operates via actin upregulation. Actin is the primary structural protein making up cell membranes. By upregulating actin, TB-500 effectively "lubricates" the movement of stem cells and myocytes, allowing repair cells to physically migrate to the injury site over vast systemic distances.
          </p>

          {/* CTA Embed */}
          <div className="my-10 rounded-2xl bg-gradient-to-br from-violet-900/40 to-zinc-900 border border-violet-500/30 p-6 shadow-xl relative overflow-hidden group">
            <div className="absolute top-0 right-0 w-32 h-32 bg-violet-500/10 blur-[50px] rounded-full pointer-events-none transition-all group-hover:bg-violet-500/20" id="sourcing" />
            <h4 className="text-xl font-bold text-zinc-100 mb-2 flex flex-wrap items-center gap-2">
              <AlertCircle className="w-5 h-5 text-violet-400" /> Need verified research grade BPC-157?
            </h4>
            <p className="text-sm text-zinc-300 mb-6 max-w-lg leading-relaxed">
              We aggregate and review the top peptide synthesis labs based strictly on independent HPLC mass spectrometry, pricing, and fulfillment speed.
            </p>
            <Link 
              href="/vendors" 
              rel="nofollow noopener sponsored" 
              className="inline-flex items-center justify-center gap-2 px-6 py-3 rounded-xl bg-violet-600 hover:bg-violet-500 text-white font-bold transition-all shadow-lg hover:shadow-violet-500/25"
            >
              Compare Trusted Vendors <ArrowRight className="w-5 h-5" />
            </Link>
          </div>

          <h2 id="clinical-differences">Localized vs Systemic Action</h2>
          <p>
            Due to its lack of systemic mobility in some tissue models, BPC-157 is heavily favored in literature for <strong>localized</strong> subcutaneous administrations near the site of tendon/ligament damage. 
          </p>
          <p>
            TB-500, however, is structurally lighter and travels freely throughout the circulatory system. In equine models (where TB-4 is extensively studied), systemic administration achieves tissue saturation regardless of the injection site—making it optimal for broad muscular tears or widespread inflammatory loads. 
          </p>

          <h2 id="how-they-stack">How the Research Prepares the Stack</h2>
          <p>
            When combined inside the <Link href="/stacks/injury-recovery">Injury Recovery Stack</Link>, these two peptides execute a flawless one-two punch: TB-500 mobilizes the necessary repair cells throughout the circulatory system, and BPC-157 builds the localized vascular network to rapidly deliver those cells precisely into the avascular tendon tissue.
          </p>

        </main>
        </AutoLink>
      </div>

      {/* FAQ Wrap-Up */}
      
      {/* Explore in Our Library */}
      <LibraryCallout currentSlug="bpc-157-vs-tb-500" peptides={[{"name":"BPC-157","slug":"bpc-157"},{"name":"TB-500","slug":"tb-500"},{"name":"GHK-Cu","slug":"ghk-cu"}]} />
{/* Citations */}
      <div className="mb-12">
        <CiteThisPage title={POST_TITLE} url={`https://peptidex.app/blog/bpc-157-vs-tb-500`} />
      </div>

      <section className="border-t border-zinc-800 pt-12 mt-12 pb-8">
        <h2 className="text-2xl font-bold text-zinc-100 text-center mb-8">Frequently Asked Questions</h2>
        <div className="max-w-3xl mx-auto space-y-4">
          {faqSchema.mainEntity.map((q, idx) => (
            <div key={idx} className="bg-zinc-900/60 border border-zinc-800 rounded-xl p-6">
              <h3 className="text-md font-bold text-zinc-200 mb-3">{q.name}</h3>
              <p className="text-zinc-400 text-sm leading-relaxed">{q.acceptedAnswer.text}</p>
            </div>
          ))}
        </div>
      </section>

      {/* Author Bio */}
      
      <ShareBar title={POST_TITLE} url={`https://peptidex.app/blog/bpc-157-vs-tb-500`} />
      <BlogVendorCallout />
      <AuthorBio name={AUTHOR} />

    </div>
  );
}
